Hem › Metastaserande cancer › Texas › Killeen
Kliniska studier för Metastaserande cancer i Killeen, TX
4 studier för Metastaserande cancer söker deltagare vid platser i och runt Killeen (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Scott and White Memorial Hospital, Temple · 23 mi bort
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekryterarFas 3
- Baylor Scott & White Medical Center-Temple, Temple · 23 mi bort
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- Baylor Scott & White Vasicek Cancer Treatment Center, Temple · 23 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Temple · 23 mi bort
Metastaserande cancer-studier i andra städer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andra studier i Killeen
- Posttraumatiskt stressyndrom8 studier
- Hjärtsvikt6 studier
- Kolorektal cancer6 studier
- Cancer (alla typer)5 studier
- Tjocktarmscancer5 studier
- Blåscancer5 studier
- Typ 2-diabetes4 studier
- Bröstcancer4 studier
- Icke-småcellig lungcancer4 studier
- Äggstockscancer4 studier
- Endometriecancer4 studier
- Burkitts lymfom3 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.